Eslami, S.M. et al. 2017. Does Evolocumab, as a PCSK9 Inhibitor, Ameliorate the Lipid Profile in Familial Hypercholesterolemia Patients? A Meta-Analysis of Randomized Controlled Trials. Journal of Pharmacy & Pharmaceutical Sciences. 20, (Apr. 2017), 81–96. DOI:https://doi.org/10.18433/J36C8N.